Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 2
2016 2
2017 1
2018 6
2019 5
2020 5
2021 2
2022 2
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Results by year

Filters applied: . Clear all
Page 1
Targeting thromboinflammation in antiphospholipid syndrome.
Salet DM, Bekkering S, Middeldorp S, van den Hoogen LL. Salet DM, et al. Among authors: van den hoogen ll. J Thromb Haemost. 2023 Apr;21(4):744-757. doi: 10.1016/j.jtha.2022.12.002. Epub 2022 Dec 22. J Thromb Haemost. 2023. PMID: 36696191 Free article. Review.
Single-Cell Analysis of Human Mononuclear Phagocytes Reveals Subset-Defining Markers and Identifies Circulating Inflammatory Dendritic Cells.
Dutertre CA, Becht E, Irac SE, Khalilnezhad A, Narang V, Khalilnezhad S, Ng PY, van den Hoogen LL, Leong JY, Lee B, Chevrier M, Zhang XM, Yong PJA, Koh G, Lum J, Howland SW, Mok E, Chen J, Larbi A, Tan HKK, Lim TKH, Karagianni P, Tzioufas AG, Malleret B, Brody J, Albani S, van Roon J, Radstake T, Newell EW, Ginhoux F. Dutertre CA, et al. Among authors: van den hoogen ll. Immunity. 2019 Sep 17;51(3):573-589.e8. doi: 10.1016/j.immuni.2019.08.008. Epub 2019 Aug 29. Immunity. 2019. PMID: 31474513 Free article.
A genome-wide association study suggests new susceptibility loci for primary antiphospholipid syndrome.
Casares-Marfil D, Martínez-Bueno M, Borghi MO, Pons-Estel G; PRECISESADS Clinical Consortium; Reales G, Zuo Y, Espinosa G, Radstake T, van den Hoogen LL, Wallace C, Guthridge J, James JA, Cervera R, Meroni PL, Martin J, Knight JS, Alarcón-Riquelme ME, Sawalha AH. Casares-Marfil D, et al. Among authors: van den hoogen ll. medRxiv [Preprint]. 2023 Dec 5:2023.12.05.23299396. doi: 10.1101/2023.12.05.23299396. medRxiv. 2023. PMID: 38405993 Free PMC article. Preprint.
Signaling by the inhibitory receptor CD200R is rewired by type I interferon.
van der Vlist M, Ramos MIP, van den Hoogen LL, Hiddingh S, Timmerman LM, de Hond TAP, Kaan ED, van der Kroef M, Lebbink RJ, Peters FMA, Khoury-Hanold W, Fritsch-Stork R, Radstake TRDJ, Meyaard L. van der Vlist M, et al. Among authors: van den hoogen ll. Sci Signal. 2021 Oct 12;14(704):eabb4324. doi: 10.1126/scisignal.abb4324. Epub 2021 Oct 12. Sci Signal. 2021. PMID: 34637328
Biomarker profiles of endothelial activation and dysfunction in rare systemic autoimmune diseases: implications for cardiovascular risk.
Wienke J, Mertens JS, Garcia S, Lim J, Wijngaarde CA, Yeo JG, Meyer A, van den Hoogen LL, Tekstra J, Hoogendijk JE, Otten HG, Fritsch-Stork RDE, de Jager W, Seyger MMB, Thurlings RM, de Jong EMGJ, van der Kooi AJ, van der Pol WL; Dutch Juvenile Myositis Consortium; Arkachaisri T, Radstake TRDJ, van Royen-Kerkhof A, van Wijk F. Wienke J, et al. Among authors: van den hoogen ll. Rheumatology (Oxford). 2021 Feb 1;60(2):785-801. doi: 10.1093/rheumatology/keaa270. Rheumatology (Oxford). 2021. PMID: 32810267
21 results